Sutro Biopharma, Inc 10-Q for FY2024 Q1
Sutro Biopharma, Inc. (STRO)
10-Q
2024-05-13
For: 2024-03-31
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on May 13, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).
Headline figures
Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $13.01M
- up 2.6% from $12.67M a year earlier
- Net loss
- $58.21M
- compared with a net loss of $50.05M a year earlier
- Diluted EPS
- -$0.95
- compared with -$0.85 a year earlier